Cargando…
Potential Cardiovascular Risk Protection of Bilirubin in End-Stage Renal Disease Patients under Hemodialysis
We evaluated the potential cardiovascular risk protection of bilirubin in hemodialysis (HD) patients. An enlarged set of studies were evaluated in 191 HD patients, including hematological study, lipid profile, iron metabolism, nutritional, inflammatory markers, and dialysis adequacy. The TA duplicat...
Autores principales: | do Sameiro-Faria, Maria, Kohlova, Michaela, Ribeiro, Sandra, Rocha-Pereira, Petronila, Teixeira, Laetitia, Nascimento, Henrique, Reis, Flávio, Miranda, Vasco, Bronze-da-Rocha, Elsa, Quintanilha, Alexandre, Belo, Luís, Costa, Elísio, Santos-Silva, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174976/ https://www.ncbi.nlm.nih.gov/pubmed/25276769 http://dx.doi.org/10.1155/2014/175286 |
Ejemplares similares
-
Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study
por: do Sameiro-Faria, Maria, et al.
Publicado: (2013) -
Body Fat Percentage Is a Major Determinant of Total Bilirubin Independently of UGT1A1*28 Polymorphism in Young Obese
por: Belo, Luís, et al.
Publicado: (2014) -
Bilirubin is independently associated with oxidized LDL levels in young obese patients
por: Nascimento, Henrique, et al.
Publicado: (2015) -
Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysis
por: Coimbra, Susana, et al.
Publicado: (2020) -
Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?
por: Coimbra, Susana, et al.
Publicado: (2021)